Brachytherapy and hyperthermia therapy developer BSD Medical of Salt Lake City has signed an exclusive patent license agreement with Duke University in Durham, NC, for the rights to Duke's hyperthermia therapy breast cancer treatment system.
BSD plans to integrate the technology with its current BSD-2000 and BSD-500 hyperthermia systems to complement radiation therapy, chemotherapy, and heat-released targeted liposome drug delivery.
In June, BSD Medical filed a patent for a new phased-array breast treatment applicator developed to selectively heat primary breast cancer tumors with the BSD-500 hyperthermia system. This pending patent and the new license with Duke University are mutually inclusive as part of BSD Medical's technology to treat primary cancers of the breast.
By AuntMinnie.com staff writers
August 14, 2006
Related Reading
NCCN adds breast cancer hyperthermia therapy to guidelines, December 14, 2006
BSD develops MicroThermX 100, August 29, 2006
BSD gets favorable patent notice, July 26, 2005
Copyright © 2007 AuntMinnie.com
